A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

  • STATUS
    Not Recruiting
  • End date
    Oct 26, 2021
  • participants needed
    5800
  • sponsor
    Janssen Vaccines & Prevention B.V.
Updated on 14 March 2021
diabetes
body mass index
hypertension
COPD
type 2 diabetes mellitus
cardiac diseases
vaccination
pulmonary disease
vaccines, rsv
respiratory tract disease
hyperlipoproteinemia

Summary

The purpose of this study is to demonstrate the efficacy of active study vaccine in the prevention of reverse transcriptase polymerase chain reaction (RT-PCR) confirmed respiratory syncytial virus (RSV)-mediated lower respiratory tract disease (LRTD), when compared to placebo.

Details
Condition Respiratory syncytial virus, Respiratory Tract Diseases
Treatment Placebo, RSV vaccine
Clinical Study IdentifierNCT03982199
SponsorJanssen Vaccines & Prevention B.V.
Last Modified on14 March 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note